Atlas Trials

Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients

Clinical trial NCT01845350 · COMPLETED

Trial details

NCT number
NCT01845350
Sponsor
Siberian Branch of the Russian Academy of Medical Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ischemic StrokeHemorrhagic Stroke
Start date
2012-10-01
Primary completion
2014-04-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.